The FDA approves AstraZeneca’s Iressa as a first-line lung-cancer therapy; Mylan and Dr. Reddy’s launch generic versions of dementia treatment Namenda; health insurer consolidation may lead to pressure on drug prices
Roche diagnostic unit partnering with drugmaker on companion diagnostic
May 27, 2015
7:00 pm
The test seeks to identify patients with metastatic pancreatic cancer and high levels of hyaluronan.